4 Healthcare Stock Stories To Further Investment Wellness On Thursday

St. Jude Medical, Inc. (NYSE:STJ): Closing price $52.14

The medical device maker announced Thursday the FDA approval and initial use of MediGuide Enabled Ablation Catheters, which are used to treat specific irregular heartbeats, expanding the innovative MediGuide platform for St. Jude Medical. The catheters can be visualized by the use of 3-D magnetic tracking. MediGuide tech is the first and only system to potentially shrink the duration of radiation exposure during catheter ablation procedures. The catheters are employed to form lesions (tiny scars) during cardiac ablation procedures to treat atrial flutter. MediGuide sensors permit the catheters to be visualized and navigated in real-time on pre-recorded fluoroscopy.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

STJ-20130815

Novartis AG (NYSE:NVS): Closing price $73.34

On Thursday, Novartis reported that the Australian Therapeutic Goods Administration has added Bexsero, which is a multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe, to the Australian Register of Therapeutic Goods for use in individuals from two months of age and up. Bexsero is the first and sole broad coverage vaccine to help guard all age groups against MenB disease, including infants who are at the largest risk of infection.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

NVS-20130815

NuVasive, Inc. (NASDAQ:NUVA): Closing price $23.59

The medical device firm centered on developing minimally disruptive surgical products and procedures for the spine, announced the expansion and relocation of its United Kingdom office. The relocation will permit NuVasive to better execute its strategy for taking market share across Northern Europe. The modern two-story, 7,500-square-foot facility adds increases warehousing capabilities, office space and provides dedicated space for staff training and surgeon events.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

NUVA-20130815

Inovio Pharmaceuticals, Inc. (AMEX:INO): Closing price $1.59

Inovio reported Thursday that its SynCon DNA vaccine containing multiple malaria antigens delivered by means of its CELLECTRA electroporation device exhibited strong and durable antibody and T-cell immune responses in small animals and non-human primates. Employing these strong preclinical results, Inovio will initiate a phase I/IIa clinical trial in 2014. These results appear in the American Society for Microbiology’s peer-reviewed journal, Infection & Immunity, in a paper entitled Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using pDNA, authored by Inovio researchers and collaborators.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

INO-20130815

Don’t Miss: This Obamacare Delay Was Hidden in the Frequently Asked Questions.

More Articles About:   , ,  

More from The Cheat Sheet